Recombinant Human Osteopontin Protein，His

Osteopontin (OPN) is a glycoprotein that plays a crucial role in various physiological and pathological processes, including bone remodeling, immune response, and tissue regeneration. Originally identified in bone, OPN is also expressed in many other tissues, indicating its diverse functions beyond skeletal health. Research has shown that OPN participates in cell adhesion, migration, and signaling pathways, which are essential for processes like inflammation and tumor progression. Given its importance in these biological processes, OPN has garnered attention as a potential therapeutic target for various diseases, including osteoporosis, cancer, and cardiovascular diseases. The recombinant form of OPN has been developed and characterized to enable detailed studies of its biological functions and interactions at the molecular level. Additionally, recombinant OPN can serve as a valuable tool for investigating its role in cell signaling and the immune system, providing insights that could lead to novel therapeutic strategies. Understanding the structure-function relationship of OPN through recombinant technology not only enhances our fundamental knowledge of its biology but also opens new avenues for clinical applications, such as developing biomaterials for bone repair or modulating immune responses in diseases. Overall, research on recombinant OPN holds promise for advancing both basic science and translational medicine, making it a significant focus in biomedical research.